TTK and hepatocellular carcinoma: Among 13 marked up-regulated genes in HCC patients, we demonstrated that TTK gene, encoding a dual specificity protein kinase essential for chromosome alignment at the centromere during mitosis and required for centrosome duplication, is a potential therapeutic target for HCC cells resistant to sorafenib.